Welcome to our dedicated page for Ethema Hlth SEC filings (Ticker: GRST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to track how many Medicaid beds Ethema Health Corporation (GRST) just licensed or which facility went through a sale-leaseback? Healthcare filings are dense—risk factors run long, reimbursement rules change fast, and every footnote matters.
Stock Titan’s AI reads each Ethema Health quarterly earnings report 10-Q filing and its sprawling annual report 10-K simplified, highlights where patient census, payer mix, and lease obligations shift, then answers the questions investors actually type: “Ethema Health SEC filings explained simply” and “understanding Ethema Health SEC documents with AI.” Real-time alerts flag every Ethema Health 8-K material events explained—whether it’s a new treatment center opening or a change in licensing status—so you never wait for tomorrow’s news.
Need insider activity? Our dashboard streams Ethema Health insider trading Form 4 transactions, delivering Ethema Health Form 4 insider transactions real-time. You can instantly see Ethema Health executive stock transactions Form 4 alongside proxy statement executive compensation data to judge alignment. For deeper diligence, AI-powered summaries map disclosures to practical use cases:
- Compare revenue per occupied bed across periods with Ethema Health earnings report filing analysis.
- Spot reimbursement-rate assumptions hidden in footnotes.
- Track acquisition progress from initial 8-K to closing 10-Q.
All filings—10-K, 10-Q, 8-K, DEF 14A, and more—arrive the moment EDGAR posts them. Complex healthcare jargon becomes clear facts, giving you the context to act before the market reacts.
Ethema Health Corporation reported sharply higher activity for the quarter ended September 30, 2025, driven by its expanded addiction treatment footprint. Quarterly revenue rose to $5.53 million from $1.76 million a year earlier, helped by the January 2025 acquisition of Edgewater Recovery Centers’ Kentucky operations. For the first nine months of 2025, revenue reached $13.95 million versus $4.55 million in the prior-year period.
Operating income for the quarter was $546,015, compared with an operating loss a year ago, and net income was $66,136, though the company still recorded a $1.11 million net loss year‑to‑date. The Edgewater transaction added customer relationships, licenses and other intangibles, plus $3.49 million of goodwill, and was funded in part by new bank debt, including a $4.25 million promissory note.
Ethema’s balance sheet remains highly leveraged. At September 30, 2025, total liabilities of $38.84 million exceeded total assets of $30.27 million, with a working capital deficit of about $12.2 million, an accumulated deficit of $45.5 million, and cash of $114,030. Management states these conditions raise substantial doubt about the company’s ability to continue as a going concern and indicates it will need additional capital and continued revenue growth to support operations.
FAQ
What is the current stock price of Ethema Hlth (GRST)?
What is the market cap of Ethema Hlth (GRST)?
